started · updated
Brazil Ministry of Health requests GLP-1 weight-loss drugs for SUS
The Brazilian Ministry of Health has formally requested that the National Commission for the Incorporation of Technologies in the Unified Health System (Conitec) evaluate including GLP-1 weight-loss medications in the SUS drug list. The proposal specifically targets the evaluation of semaglutide and liraglutide, noting that these active ingredients no longer have patent protection.
The The Ministry cited a significant rise in obesity prevalence in Brazil, which grew from 11.8% in 2006 to 25.7% in 2024. Officials argued that providing long-term access to these therapies could reduce mortality, improve quality of life, and lower overall healthcare costs. This move aligns with World Health Organization guidelines regarding equitable access to obesity treatments.
The request follows a previous rejection by Conitec in August due to high financial impact. However, the Ministry claims the economic landscape has changed, noting that increased market competition has reduced the retail cost of these medications by approximately 70% in less than a year. Currently, 25 weight-loss pens are registered in Brazil, including several national and generic versions.
Entities
Alexandre Padilha · Anvisa · Bestware · Brazil · Conitec · Fernando Yunes · Luiz Inácio Lula da Silva · Mercado Livre · Ministry of Health · Ministério da Saúde · Pague Menos · Panvel
Claims
What the coverage asserts, and how many sources carry each claim.
- [○ 1 SOURCE] The campaign aims to increase national production's share in SUS supply from 40% to 70%.
- [● 2 SOURCES] Prices for weight-loss pens in Brazil have decreased by 70% in less than a year due to increased competition. momentomt.com.br · www.metropoles.com
- [● 10 SOURCES] Obesity prevalence in Brazil rose from 11.8% in 2006 to 25.7% in 2024. momentomt.com.br · portaldiarioderondonia.com · www.estadao.com.br · esportenaredemt.com.br · sidneysilva.com.br · +3 more
- [● 3 SOURCES] President Lula announced that weight-loss pens would be offered for free through the SUS. www.metropoles.com · www.estadao.com.br · oaltoacre.com
- [● 16 SOURCES] The proposal requests the evaluation of semaglutide or liraglutide, which are active ingredients without patent protection. momentomt.com.br · www.metropoles.com · portaldiarioderondonia.com · www.acessa.com · www.estadao.com.br · +9 more
- [● 4 SOURCES] The Ministry is testing a protocol with approximately 250 people with severe obesity at Grupo Hospitalar Conceição in Porto Alegre. www.metropoles.com · oaltoacre.com · amazoniaonline.com.br
- [● 29 SOURCES] The Ministry of Health filed a request with Conitec to analyze the incorporation of GLP-1 weight-loss medications into the SUS. momentomt.com.br · www.metropoles.com · portaldiarioderondonia.com · www.acessa.com · www.estadao.com.br · +21 more
- [○ 1 SOURCE] The Lula campaign proposes transforming the SUS into a digital, connected system through IT investments.
- [● 2 SOURCES] The 'Envios Agora' service offers deliveries in up to one hour for products up to 15 kg.
- [● 2 SOURCES] Mercado Livre will begin selling prescription medications in Brazil starting September 25.
- [● 27 SOURCES] Competition has reduced the cost of weight-loss medications in Brazil by 70% in less than a year. portaldiarioderondonia.com · esportenaredemt.com.br · oaltoacre.com · cenariomt.com.br · www.acessa.com · +19 more
- [● 25 SOURCES] The Ministry of Health requested Conitec to include GLP-1 weight-loss pens in the SUS drug list. portaldiarioderondonia.com · www.estadao.com.br · esportenaredemt.com.br · sbtnews.sbt.com.br · sidneysilva.com.br · +18 more